Constitutively active ADAMTS13: An emerging thrombolytic agent for acute ischemic stroke.
作者信息
Nayak Manasa K, Flora Gagan D, Chauhan Anil K
机构信息
Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
出版信息
J Thromb Haemost. 2022 Apr;20(4):790-793. doi: 10.1111/jth.15649. Epub 2022 Feb 2.
Abstract
摘要
相似文献
1
Constitutively active ADAMTS13: An emerging thrombolytic agent for acute ischemic stroke.组成型活性ADAMTS13：一种用于急性缺血性卒中的新型溶栓剂。
J Thromb Haemost. 2022 Apr;20(4):790-793. doi: 10.1111/jth.15649. Epub 2022 Feb 2.
2
Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion.急性缺血性脑卒中再灌注的新兴辅助溶栓治疗。
Stroke. 2024 Oct;55(10):2536-2546. doi: 10.1161/STROKEAHA.124.045755. Epub 2024 Aug 6.
3
Thrombolysis in extended time window for acute ischemic stroke during pregnancy.孕期急性缺血性卒中延长时间窗内的溶栓治疗
Clin Neurol Neurosurg. 2023 May;228:107713. doi: 10.1016/j.clineuro.2023.107713. Epub 2023 Apr 6.
4
Postpartum ischemic stroke: a successful intravenous thrombolysis.产后缺血性卒中：一例成功的静脉溶栓治疗
Acta Neurol Belg. 2023 Feb;123(1):271-274. doi: 10.1007/s13760-021-01789-w. Epub 2021 Oct 18.
5
Restricted access in the emergency department prevents MRI from being the workhorse for ischemic stroke care.急诊科的受限准入使得磁共振成像（MRI）无法成为缺血性中风治疗的主力手段。
J Neurol Sci. 2023 May 15;448:120637. doi: 10.1016/j.jns.2023.120637. Epub 2023 Mar 26.
6
A new thrombolytic drug for acute ischaemic stroke.一种用于急性缺血性中风的新型溶栓药物。
Lancet Neurol. 2021 Sep;20(9):687-689. doi: 10.1016/S1474-4422(21)00256-8.
7
In ischemic stroke upon wakening, IV thrombolysis or EVT improves functional outcome at 90 d.在缺血性卒中后觉醒时，静脉溶栓或血管内治疗可改善 90 天的功能结局。
Ann Intern Med. 2022 Apr;175(4):JC41. doi: 10.7326/J22-0020. Epub 2022 Apr 5.
8
Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models.一种持续激活的 ADAMTS13 变异体在小鼠卒中模型中的溶栓和抗炎作用。
Blood. 2022 Mar 10;139(10):1575-1587. doi: 10.1182/blood.2021012787.
9
Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.替奈普酶能否取代阿替普酶？急性缺血性卒中溶栓治疗的比较：2023年6月《急诊医学年鉴》期刊俱乐部
Ann Emerg Med. 2023 Jun;81(6):759-760. doi: 10.1016/j.annemergmed.2023.04.012.
10
One-shot thrombolysis for the management of acute ischaemic stroke.单次溶栓治疗急性缺血性卒中
Eur Heart J. 2022 Oct 11;43(38):3616-3617. doi: 10.1093/eurheartj/ehac457.
本文引用的文献
1
Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models.一种持续激活的 ADAMTS13 变异体在小鼠卒中模型中的溶栓和抗炎作用。
Blood. 2022 Mar 10;139(10):1575-1587. doi: 10.1182/blood.2021012787.
2
Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.体外和急性缺血性脑卒中小鼠模型中，ADAMTS-13 变异体（R568K/F592Y/R660K/Y661F/Y665F）对血小板聚集的活性增强。
J Thromb Haemost. 2018 Nov;16(11):2289-2299. doi: 10.1111/jth.14275. Epub 2018 Oct 24.
3
Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.内皮细胞衍生的血管性血友病因子而非血小板衍生的促进载脂蛋白 E 缺陷小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):520-528. doi: 10.1161/ATVBAHA.117.309918. Epub 2018 Jan 18.
4
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.发病后 6 至 24 小时内进行取栓术治疗与缺损和梗死不匹配的脑卒中。
N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
5
Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.内皮细胞衍生的血管性血友病因子是通过促进缺血后血栓炎症介导血管性血友病因子依赖性急性缺血性卒中的主要决定因素。
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1829-37. doi: 10.1161/ATVBAHA.116.307660. Epub 2016 Jul 21.
6
Determining the Number of Ischemic Strokes Potentially Eligible for Endovascular Thrombectomy: A Population-Based Study.确定适合血管内血栓切除术的缺血性中风数量：基于人群的研究。
Stroke. 2016 May;47(5):1377-80. doi: 10.1161/STROKEAHA.116.013165. Epub 2016 Mar 17.
7
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.ADAMTS13 介导的溶栓治疗对缺血性脑卒中 t-PA 抵抗性闭塞的作用。
Blood. 2016 May 12;127(19):2337-45. doi: 10.1182/blood-2015-08-662650. Epub 2016 Feb 29.
8
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.血管内血栓切除术治疗大动脉闭塞性缺血性卒中的Meta 分析：来自五项随机试验的个体患者数据汇总分析
Lancet. 2016 Apr 23;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X. Epub 2016 Feb 18.
9
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.静脉注射阿替普酶用于急性缺血性脑卒中的纳入和排除标准的科学依据：美国心脏协会/美国卒中协会医疗保健专业人员的声明。
Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22.
10
Conformational activation of ADAMTS13.ADAMTS13的构象激活
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18578-83. doi: 10.1073/pnas.1411979112. Epub 2014 Dec 15.
Zotero 插件